Neurofenac capsules

Recall | Medicines | 28/11/2017

The marketing authorization holder informed its supplied customers in a letter dated 27.11.2017 that the stability test did not comply with the test for gastric juice resistance. The potential impact on patient safety is assessed as low. All other batches available in Austria are not affected by this recall.

Name of the medicinal product Neurofenac-Kapseln
Marketing authorisation number(s) 1-18584
Marketing authorisation holder Merck Gesellschaft mbH
Batch number(s) 025817A, 025817B, 025817C, 025817D und 025817E
Classification of the recallII
BASG reference number INS-640.001-2347

Further inquiry note